VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 57 filers reported holding VOR BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,624 | -54.5% | 8,313 | -33.7% | 0.00% | – |
| Q2 2023 | $38,727 | -22.5% | 12,533 | +52.5% | 0.00% | – |
| Q1 2022 | $50,000 | -58.0% | 8,221 | -19.8% | 0.00% | – |
| Q4 2021 | $119,000 | -26.1% | 10,252 | 0.0% | 0.00% | – |
| Q3 2021 | $161,000 | -45.2% | 10,252 | -34.9% | 0.00% | – |
| Q2 2021 | $294,000 | -60.4% | 15,746 | -8.5% | 0.00% | -100.0% |
| Q1 2021 | $742,000 | – | 17,211 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,361,723 | $34,226,070 | 8.75% |
| OUP Management Co., LLC | 374,714 | $2,015,961 | 4.02% |
| Paradigm Biocapital Advisors LP | 6,477,999 | $34,851,635 | 3.30% |
| RA Capital Management | 22,748,880 | $122,388,974 | 2.77% |
| JOHNSON & JOHNSON | 1,074,658 | $5,781,660 | 1.88% |
| Artal Group S.A. | 2,792,805 | $15,025 | 0.89% |
| Trustees of Columbia University in the City of New York | 91,910 | $494,476 | 0.88% |
| Sarissa Capital Management LP | 618,000 | $3,324,840 | 0.42% |
| Laurion Capital Management LP | 3,182,889 | $17,123,943 | 0.12% |
| Woodline Partners LP | 1,111,123 | $5,977,842 | 0.08% |